Talis Biomedical Corporation

Talis Biomedical Corporation is a molecular diagnostic company that is focused on developing the Talis One system to improve point-of-care diagnostic testing for infectious diseases. The company's primary revenue comes from the Talis One COVID-19 Test System, designed for the detection of SARS-CoV-2, the virus responsible for COVID-19. Additionally, it offers assay kits for respiratory infections, women's health-related infections, and sexually transmitted infections. The company also provides tests for other respiratory infections, including a respiratory panel test for influenza A, influenza B, and respiratory syncytial virus.

Products

• Talis One COVID-19 Test System

• Assay kits for various infections

• Respiratory panel tests